Computational identification and experimental validation of potential inhibitors of JAK1 kinase from natural source for the effective treatment of colorectal adenocarcinoma
Article in South African Journal of Botany (August 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
Article in The Lancet Oncology (December 2023)
Synthesis and clinical application of small-molecule inhibitors of Janus kinase
Article in European Journal of Medicinal Chemistry (September 2023)